Corrigendum to “Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer” [Translational Oncology (2019) 12, 764–774]

• Dabo Zhou,
• Liping Liu,
• Jingyu Liu,
• Yu Tang,
• Mengjia Xiao,
• Yikai Wang,
• Qiongzhi He,
• Zhe-Yu Hu,
• Quchang Ouyang

Affiliations

Dabo Zhou

Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China

Liping Liu

Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China

Jingyu Liu

Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China

Yu Tang

Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China

Mengjia Xiao

Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China

Yikai Wang

Department of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Atlanta, 33022, USA

Qiongzhi He

Geneplus Beijing Institute, Beijing 102206, China

Zhe-Yu Hu

Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China; Corresponding authors at: No. 283, Tongzipo Road, Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, 410013, P.R. China.

Quchang Ouyang

Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha 410013, China; Corresponding authors at: No. 283, Tongzipo Road, Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, 410013, P.R. China.